Literature DB >> 15143186

Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate.

Pablo Rodriguez-Viciana1, Celine Sabatier, Frank McCormick.   

Abstract

Ras family GTPases (RFGs) regulate signaling pathways that control multiple biological processes. How signaling specificity among the closely related family members is achieved is poorly understood. We have taken a proteomics approach to signaling by RFGs, and we have analyzed interactions of a panel of RFGs with a comprehensive group of known and potential effectors. We have found remarkable differences in the ability of RFGs to regulate the various isoforms of known effector families. We have also identified several proteins as novel effectors of RFGs with differential binding specificities to the various RFGs. We propose that specificity among RFGs is achieved by the differential regulation of combinations of effector families as well as by the selective regulation of different isoforms within an effector family. An understanding of this new level of complexity in the signaling pathways regulated by RFGs is necessary to understand how they carry out their many cellular functions. It will also likely have critical implications in the treatment of human diseases such as cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143186      PMCID: PMC416418          DOI: 10.1128/MCB.24.11.4943-4954.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  80 in total

1.  The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1.

Authors:  Sara Ortiz-Vega; Andrei Khokhlatchev; Maria Nedwidek; Xian-feng Zhang; Reinhard Dammann; Gerd P Pfeifer; Joseph Avruch
Journal:  Oncogene       Date:  2002-02-21       Impact factor: 9.867

2.  14-3-3 antagonizes Ras-mediated Raf-1 recruitment to the plasma membrane to maintain signaling fidelity.

Authors:  Yvonne Light; Hugh Paterson; Richard Marais
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

3.  Tiam1 mediates Ras activation of Rac by a PI(3)K-independent mechanism.

Authors:  John M Lambert; Que T Lambert; Gary W Reuther; Angeliki Malliri; David P Siderovski; John Sondek; John G Collard; Channing J Der
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

Review 4.  A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases.

Authors:  Lawrence A Quilliam; John F Rebhun; Ariel F Castro
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2002

5.  Induction of neurite extension and survival in pheochromocytoma cells by the Rit GTPase.

Authors:  Michael L Spencer; Haipeng Shao; Douglas A Andres
Journal:  J Biol Chem       Date:  2002-03-25       Impact factor: 5.157

6.  Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation.

Authors:  Gretchen A Murphy; Suzanne M Graham; Staeci Morita; Sarah E Reks; Kelley Rogers-Graham; Anne Vojtek; Grant G Kelley; Channing J Der
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

7.  Identification of a novel Ras-regulated proapoptotic pathway.

Authors:  Andrei Khokhlatchev; Shahrooz Rabizadeh; Ramnik Xavier; Maria Nedwidek; Tao Chen; Xian-feng Zhang; Brian Seed; Joseph Avruch
Journal:  Curr Biol       Date:  2002-02-19       Impact factor: 10.834

8.  R-Ras3/M-Ras induces neuronal differentiation of PC12 cells through cell-type-specific activation of the mitogen-activated protein kinase cascade.

Authors:  Alec C Kimmelman; Nelson Nuñez Rodriguez; Andrew M-L Chan
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

Review 9.  Distinct requirements for Ras oncogenesis in human versus mouse cells.

Authors:  Nesrin M Hamad; Joel H Elconin; Antoine E Karnoub; Wenli Bai; Jeremy N Rich; Robert T Abraham; Channing J Der; Christopher M Counter
Journal:  Genes Dev       Date:  2002-08-15       Impact factor: 11.361

10.  Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells.

Authors:  C A Pritchard; M L Samuels; E Bosch; M McMahon
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

View more
  127 in total

1.  PAQR10 and PAQR11 mediate Ras signaling in the Golgi apparatus.

Authors:  Ting Jin; Qiurong Ding; Heng Huang; Daqian Xu; Yuhui Jiang; Ben Zhou; Zhenghu Li; Xiaomeng Jiang; Jing He; Weizhong Liu; Yixuan Zhang; Yi Pan; Zhenzhen Wang; Walter G Thomas; Yan Chen
Journal:  Cell Res       Date:  2011-10-04       Impact factor: 25.617

2.  Cooperative activation of PI3K by Ras and Rho family small GTPases.

Authors:  Hee Won Yang; Min-Gyoung Shin; Sangkyu Lee; Jeong-Rae Kim; Wei Sun Park; Kwang-Hyun Cho; Tobias Meyer; Won Do Heo
Journal:  Mol Cell       Date:  2012-06-07       Impact factor: 17.970

Review 3.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

Review 4.  Metastasis: tumor cells becoming MENAcing.

Authors:  Frank Gertler; John Condeelis
Journal:  Trends Cell Biol       Date:  2010-11-09       Impact factor: 20.808

5.  Biased binding of class IA phosphatidyl inositol 3-kinase subunits to inducible costimulator (CD278).

Authors:  Yenny Y Acosta; Maria Paz Zafra; Gloria Ojeda; Ilaria Seren Bernardone; Umberto Dianzani; Pilar Portolés; Jose M Rojo
Journal:  Cell Mol Life Sci       Date:  2010-12-28       Impact factor: 9.261

6.  Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas.

Authors:  Braden D Siempelkamp; Manoj K Rathinaswamy; Meredith L Jenkins; John E Burke
Journal:  J Biol Chem       Date:  2017-05-17       Impact factor: 5.157

7.  The structure of Rap1 in complex with RIAM reveals specificity determinants and recruitment mechanism.

Authors:  Hao Zhang; Yu-Chung Chang; Mark L Brennan; Jinhua Wu
Journal:  J Mol Cell Biol       Date:  2013-11-28       Impact factor: 6.216

Review 8.  Targeted therapies in melanoma.

Authors:  Stergios J Moschos; Ramya Pinnamaneni
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

9.  Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.

Authors:  Barbara Geering; Pedro R Cutillas; Gemma Nock; Severine I Gharbi; Bart Vanhaesebroeck
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

10.  The differential effects of wild-type and mutated K-Ras on MST2 signaling are determined by K-Ras activation kinetics.

Authors:  David Romano; Helene Maccario; Carolanne Doherty; Niall P Quinn; Walter Kolch; David Matallanas
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.